Latest

This main section contains 4 sections:

News - Latest

95 news items

Enter search criteria

Fill in keyword(s) to narrow your search.

2nd Edition of MEB Regulatory Science Magazine released

Today, the 2nd edition of the Regulatory Science Magazine was released. This online magazine, produced by the Medicines...

News item | 15-06-2017 | 16:00

Assessment criteria for combination packages policy established

The Medicines Evaluation Board (MEB) has described the terms and conditions which are to be used to assess applications for...

News item | 15-06-2017 | 15:00

MEB Annual Report: a leading player in Europe again in 2016

The Medicines Evaluation Board (MEB) was one of the leading players in Europe in the field of medicine assessment and...

News item | 08-06-2017 | 09:00

New legal EudraVigilance obligations as of 22 November 2017

As of 22 November 2017 new obligations in respect of signal management and reporting of suspected adverse reactions (ADRs) will...

News item | 06-06-2017 | 13:00

Eric Boersma sworn in as new MEB Member

Mr Prof H. (Eric) Boersma was sworn in as a new member of the Medicines Evaluation Board (MEB) on 1 June 2017.

News item | 02-06-2017 | 10:00

Anthonius (Ton) de Boer new MEB chairman

Prof. Ton de Boer is to take over as the new chairman of the Medicines Evaluation Board (MEB) as of 1 August 2017. This was...

News item | 01-06-2017 | 14:00

MEB starts technical validation of electronic submissions as from 1 June 2017

Submissions concerning human medicinal products must be submitted electronically to the Medicines Evaluation Board (MEB). As...

News item | 29-05-2017 | 12:00

Confirmation of names for influenza strains

The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for...

News item | 08-05-2017 | 11:00

Health Care Inspectorate (IGZ) request to marketing authorisation holders: questionnaire for pharmacovigilance

The Dutch Health Care Inspectorate (IGZ) has developed a risk model for pharmacovigilance to obtain more insight into the risks...

News item | 18-04-2017 | 08:00

Policy for the national informed consent marketing authorisation application

A company that wants to apply for a marketing authorisation for a medicinal product that is identical to another product that...

News item | 14-04-2017 | 14:00

Stay informed